Cite
HARVARD Citation
Azuara, D. et al. (2018). New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients. Inflammatory bowel diseases. 24 (12), pp. 2555-2564. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Azuara, D. et al. (2018). New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients. Inflammatory bowel diseases. 24 (12), pp. 2555-2564. [Online].